Literature DB >> 29194193

Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor.

Xue-Qian Qian1, Xiao-Ping Hua, Juan-Hong Wu, Yuan-Ming Shen, Xiao-Dong Cheng, Xiao-Yun Wan.   

Abstract

AIM: This study was aimed to evaluate the risk factors of recurrence and the value of nodal involvement in patients with serous borderline ovarian tumors (SBOT).
METHODS: Two hundred twenty-five patients who underwent surgery and were diagnosed with SBOT were retrospectively studied. Univariate and multivariate analyses were used to assess the risk factors for recurrence. Patients' clinical pathologic characteristics were compared between the patients who presented lymph node involvement and those who did not. The significant values of lymph condition influencing 5-year disease-free survival were also evaluated by statistical analysis.
RESULTS: Both univariate and multivariate analyses showed that risk factors for recurrence were micropapillary (P = 0.021), fertility-preserving surgery (P = 0.014), and laparoscopic approach (P = 0.009). Of these 112 patients on whom lymphadenectomy was performed, 17 cases showed lymph node positive, whereas the remaining 95 patients did not. Significant differences in terms of lymph node numbers (P < 0.0001), invasive implant (P = 0.022), and International Federation of Gynecology and Obstetrics staging (P < 0.0001) were observed between the 2 groups of lymphatic node involved or not. Kaplan-Meier curves of 5-year disease-free survival revealed that there were no significant differences either between groups of lymphatic node involved or not (P = 0.778) and groups of removed nodes whether more than 10 or not (P = 0.549).
CONCLUSIONS: Micropapillary, fertility-preserving, and laparoscopic approach were factors significantly affecting the recurrence of SBOT by both univariate and multivariate analysis. Lymph node metastasis did not seem to be correlated to a worse prognosis of SBOT.

Entities:  

Mesh:

Year:  2018        PMID: 29194193     DOI: 10.1097/IGC.0000000000001154

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  Significance of lymph node ratio on survival of women with borderline ovarian tumors.

Authors:  David J Nusbaum; Rachel S Mandelbaum; Hiroko Machida; Shinya Matsuzaki; Lynda D Roman; Anil K Sood; David M Gershenson; Koji Matsuo
Journal:  Arch Gynecol Obstet       Date:  2020-04-17       Impact factor: 2.344

2.  Serous borderline tumor of the ovary with isolated cardiophrenic lymph node spread at diagnosis.

Authors:  J D St Laurent; A A Gockley; A M Cathcart; E Baranov; D L Kolin; M J Worley
Journal:  Gynecol Oncol Rep       Date:  2020-06-01

Review 3.  The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review.

Authors:  Sameera Rashid; Maria A Arafah; Mohammed Akhtar
Journal:  Adv Anat Pathol       Date:  2022-05-01       Impact factor: 3.875

Review 4.  The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age.

Authors:  Luigi Della Corte; Antonio Mercorio; Paolo Serafino; Francesco Viciglione; Mario Palumbo; Maria Chiara De Angelis; Maria Borgo; Cira Buonfantino; Marina Tesorone; Giuseppe Bifulco; Pierluigi Giampaolino
Journal:  Front Surg       Date:  2022-08-23

Review 5.  Serous borderline ovarian tumours: an extensive review on MR imaging features.

Authors:  Hilal Sahin; Asli Irmak Akdogan; Janette Smith; Jeries Paolo Zawaideh; Helen Addley
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

Review 6.  Borderline ovarian tumours: management in the era of fertility-sparing surgery.

Authors:  Mattia Maramai; Fabio Barra; Mario Valenzano Menada; Sara Stigliani; Melita Moioli; Sergio Costantini; Simone Ferrero
Journal:  Ecancermedicalscience       Date:  2020-05-06

7.  Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database.

Authors:  Pei Luo; Jian-Guo Zhou; Su-Han Jin; Ming-Song Qing; Hu Ma
Journal:  J Ovarian Res       Date:  2019-12-30       Impact factor: 4.234

8.  Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases.

Authors:  Na Li; Jinhai Gou; Lin Li; Xiu Ming; Ting Wenyi Hu; Zhengyu Li
Journal:  BMC Cancer       Date:  2020-08-17       Impact factor: 4.430

9.  Predicting Lymph Node Involvement in Borderline Ovarian Tumors with a Quantitative Model and Nomogram: A Retrospective Cohort Study.

Authors:  Menglei Zhang; Fangyue Zhou; Yuan He; Xiang Tao; Keqin Hua; Jingxin Ding
Journal:  Cancer Manag Res       Date:  2021-02-16       Impact factor: 3.989

10.  Analysis of Factors Influencing Relapse and Pregnancy in Patients with Borderline Ovarian Tumors.

Authors:  Ya Qi; Min Wang; Yuwei Yang; Zhi Zeng; Yingying Zhou
Journal:  J Cancer       Date:  2021-07-02       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.